Cytotherapy | |
Cover: | Cytotherapy (journal).jpg |
Editor: | Edwin Horwitz |
Discipline: | Cell biology, immunology, stem cells |
Formernames: | Cytokines, Cellular and Molecular Therapy; Cytokines and Molecular therapy |
Abbreviation: | Cytotherapy |
Publisher: | Elsevier on behalf of the International Society for Cell & Gene Therapy |
Frequency: | 12/year |
History: | 1999-present |
Impact: | 5.414 |
Impact-Year: | 2020 |
Website: | https://www.isct-cytotherapy.org/ |
Link1: | https://www.isct-cytotherapy.org/current |
Link1-Name: | Online access |
Link2: | https://www.journals.elsevier.com/cytotherapy |
Link2-Name: | Online archive |
Oclc: | 288963798 |
Lccn: | 00243205 |
Coden: | CYTRF3 |
Issn: | 1465-3249 |
Eissn: | 1477-2566 |
Cytotherapy is a peer-reviewed medical journal covering the areas of cell and gene therapy. The journal was established in 1999 and is published by Elsevier on behalf of the International Society for Cell & Gene Therapy (ISCT). Cytotherapy is edited by Editor-in-Chief Edwin Horwitz, Managing Editor Kenneth W. Witwer, Commissioning Editor Patrick Hanley, and Assistant Editor Rachel Burga.
The Journal publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell and gene therapy. Cytotherapy publishes articles exploring the following topics:
This journal is abstracted and indexed in Science Citation Index Expanded, Current Contents/Clinical Medicine, Current Contents/ Life Sciences, BIOSIS Previews, and MEDLINE/PubMed. According to the Journal Citation Reports, the journal has a 2020 impact factor of 5.414.[1]